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Lipids play critical roles in the biology of Mycobacterium tuberculosis, a notorious pathogen of man, but
a systems-level approach to study these molecules have lagged behind other ‘‘omics’’ approaches. In this
issue, Layre et al. describe the development of a powerful lipidomics technique and creation of a comprehen-
sive database that address this need.Species of the order Actinomycetales,
which include Streptomyces and Myco-
bacteria, are unique in their amazing
capacity for synthesizing a wide array
of hydrophobic lipids and secondary
metabolites. Perhaps the most notorious
actinomycete, Mycobacterium tubercu-
losis, is a pathogen that has coevolved
with its human host for millennia and still
exerts an enormous toll on global health
(World Health Organization, 2011). We
have known from studies that date
back to the 1950s that M. tuberculosis
is rich in lipids (Sorkin et al., 1952),
many of which are on the surface of
the complex cell wall and exert profound
effects on bacterial interactions with the
environment as well as provide barrier
functions to the cell (Brennan and Ni-
kaido, 1995). Indeed, the elucidation of
the M. tuberculosis genome in 1998
reflected the bacterium’s substantial
lipid biosynthetic capacity (Cole et al.,
1998). Subsequent genetic and bio-
chemical studies have since shown that
some of the many lipid-associated
genes can be placed into biosynthetic
pathways, some of which are critical
for virulence in animal models of
infection. However, much remains un-
known about the composition of the
M. tuberculosis lipidome. In this issue,
Layre et al. (2011) report an impressive
technological achievement of lipidomics,
and provide an unprecedented and
comprehensive catalog of the lipidic
metabolites of this important pathogen.
This work, in combination with another
group taking a similar approach (Sartain
et al., 2011), represents an important
milestone that will catalyze our under-
standing of the role of lipids in
M. tuberculosis biology.Layre et al. (2011) overcame a number
of obstacles inherent in such an ambitious
endeavor. Previous lipididomic studies
withM. tuberculosis have used high reso-
lution mass spectrometry (MS) or liquid
chromatography mass spectrometry
(LC-MS) but these methods were limited
in the number of lipid species detected
by several problems presented by the
M. tuberculosis lipidome. First, the sheer
number of species in the M. tuberculosis
lipidome results in mass spectra peak
overlap. This problem is partially solved
by using high-resolution mass spectrom-
eters (Jain et al., 2007), which can distin-
guish many lipids in complex crude
extracts, but many ions still have overlap-
ping spectra and thus cannot be distin-
guished. Another problem derives from
the fact that in complex mixtures, some
lipid species suppress the ionization
of others, preventing their detection.
Other studies utilizing LC-MS to separate
lipids prior to MS were developed to
examine only a few specific lipids and
lacked the ability to separate other
classes of mycobacterial lipids (Low
et al., 2009), and global LC-MS methods
developed for other bacteria poorly sepa-
rate the abundant apolar lipids found in
M. tuberculosis. Layre et al. (2011) over-
came these limitations by developing
a single-step method to effectively sepa-
rate these species, resulting in a relatively
straightforward protocol to globally
monitor M. tuberculosis lipids. This has
revealed over 100,000 MS peaks, repre-
senting 5,000 lipid species that can be
reliably and reproducibly detected from
bacteria grown in standard culture.
The second problem limiting lipidomic
approaches in M. tuberculosis is the lack
of a database cataloging the myriad ofChemistry & Biology 18, December 23, 2011 ªunique lipid species synthesized by
mycobacteria. For eukaryotic cells, the
LIPID MAPS consortium of lipidomics
researchers has generated a powerful
database that includes many resources,
such as the structures and annotations
of biologically important lipids as well
as common protocols, that serve as
useful tools for the research community
(Schmelzer et al., 2007). Unfortunately,
although this database contains informa-
tion about common lipids such as glyc-
erophospholipids and triacylglycerols,
these databases obviously lack entries
about the many unique lipids found in
Mycobacteria, such as sulfolipids and
phenolic glycolipids. Indeed, of the 58
lipid families already identified in
M. tuberculosis, 40 have no counterparts
in eukaryotic cells or gram-negative bac-
teria. Therefore, Layre et al. (2011) have
also established a database similar to
LIPID MAPS, termed MycoMass, which
serves to match ions identified by MS
to known chemical structures. This
database will serve as a powerful tool
for the study of M. tuberculosis, and
as more structures are identified from
M. tuberculosis and other lipid-rich
bacteria, we envision that this tool will
become of increasing benefit to the
greater bacterial research community.
One of the benefits of this comprehen-
sive approach is that it represents an
important step in elucidating the chem-
ical and structural entirety of the
M. tuberculosis cell. The fact that only
20% of the ions detected by the authors
matched known structures in the Myco-
Mass database, however, indicates there
are still many lipids produced by
M. tuberculosis that remain unidentified.
The comprehensive dataset of ions2011 Elsevier Ltd All rights reserved 1517
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Previewsdetected will certainly aid in elucidating
their structures, identifying their biosyn-
thetic pathways, and determining their
role in M. tuberculosis biology.
Importantly, the quantitative and repro-
ducible data generated from this LC-MS
approach will allow for future comparative
studies to probe dynamic changes in the
global lipidome. It is clear that changes
in lipid content allow for M. tuberculosis
to adapt to a variety of different condi-
tions, including upon encountering stress
(Cunningham and Spreadbury, 1998) and
during infection (Kondo et al., 1970). The
technology developed by Layre et al.
(2011) will allow for a systems approach
to study these types of dynamic changes.
Indeed, the authors have demonstrated
that this method can sensitively detect
mycobacterial species even in extracts
from M. tuberculosis-infected tissue
‘‘contaminated’’ with eukaryotic lipids.
Understanding the changes that occur to
the lipidome during infection or conditions
that mimic infection such as reactive
oxygen or nitrogen stress, low iron, and1518 Chemistry & Biology 18, December 23,hypoxia, will be important to understand
the role of lipids in virulence and the
metabolic changes that occur during
infection.
Approaches to globally monitor nu-
cleic acids, proteins, and the water-
soluble metabolites within cells have
revolutionized our understanding of
M. tuberculosis biology. The absence
of similar methodologies to monitor
hydrophobic lipids has been a glaring
deficiency, especially given the impor-
tant roles of these molecules during
infection. The lipidomic platform pio-
neered by Layre et al. (2011) will allow
researchers to finally probe this final
frontier of the mycobacterial cell.REFERENCES
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Although the clinical safety of compounds targeting the core components of the Wnt signaling pathway
remains to be determined, a simple in vivo chemical screen identifies small molecules that inhibit Wnt
signaling in a cell type-specific manner (Ni et al., this issue of Chemistry & Biology).The Wnt/b-catenin signaling pathway is
undoubtedly one of the most prominent
biological pathways. In 1987, Roel
Nusse’s group showed that the mouse
mammary oncogene int-1 was the
homolog of the Drosophila segment
polarity gene wingless (Rijsewijk et al.,
1987). Thereafter, the name ‘‘Wnt,’’
derived from the combined names of
wingless and int-1, rightly signifies its
myriad roles in regulating embryonic
development and the homeostasis of
adult tissues. In addition, aberrant Wnt
signaling may cause cancers and otherdiseases (Clevers, 2006). Although in-
hibitors that target Wnt signaling ubiqui-
tously may seemingly have the broadest
utility, their potential for pleiotropic effects
on adult tissues remains a concern.
Conceivably, inhibitors that target cell
type-specific components of the Wnt
pathway may have better safety profiles.
Why has such a compound not turned
up in the screens that have been per-
formed? Is discovery of tissue-specific
Wnt inhibitors possible? In this issue, Ni
et al. (2011) provide the first example
of a tissue-specific Wnt inhibitor anddemonstrate its potential for expanding
cardiac progenitor cells.
Myocardial infarctions cause significant
clinical problems in Western society.
Thus, cardiogenic compounds are sought
after for they may reactivate cardiac
progenitors and repopulate infarcted
myocardium. Several signaling pathways
have been implicated in the genesis of
cardiac progenitors from pluripotent
stem cells. Moreover, a number of tar-
geted and screening approaches for the
identification of cardiogenic compounds
have been reported (Hao et al., 2008;
